BioSpace News Archive

Universal Serum is the flagship product of Laboratoire Synbionyme, a Paris-based beauty care company that has pioneered probiotic skin care.

Three American pharmacologists in 1998 discovered the vital role that nitric oxide plays in human health.

Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced today that it had entered into an agreement with Dorian Therapeutics to provide access to one of its novel small molecule libraries specifically designed to target deubiquitylase (DUB) enzymes.

Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France

Gala Therapeutics, Inc. announced new results from the initial study of its investigational RheOxTM device, demonstrating the safety and feasibility of Bronchial RheoplastyTM therapy to provide clinical benefit to patients with chronic bronchitis.

Immunovant, a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients living with debilitating autoimmune diseases, today announced that it has initiated dosing in ASCEND-GO 1, an open label, single-arm Phase 2a clinical trial evaluating IMVT-1401 in patients with moderate-to-severe active Graves’ ophthalmopathy

BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel CELL+GENE™ platform to develop regenerative medicines for intractable diseases, announced that the company will present at the following upcoming conferences.

Tmunity Therapeutics, Inc. announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, and members of the management team plan to participate at an investor conference in June 2019.

Long-term data demonstrate that the DynamX Bioadaptor implant and vessel growth accommodates neo-intimal hyperplasia to substantially maintain vessel lumen area in the treatment of coronary artery disease

AFYX Therapeutics announced findings from the development of a novel Oral Lichen Planus Symptom Severity Measure as a tool used to assess patients’ symptom experience on a daily basis.